Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

Composite endpoints are widely used in large randomised cardiovascular outcome trials. They are frequently referred to as ...

Background Extensions to Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) reporting recommendations specifically for ...

The expert faculty transition to a discussion on emerging therapies for high-risk, Bacillus Calmette–Guérin (BCG)-naïve non–muscle invasive bladder cancer (NMIBC), focusing on the wave of ongoing ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. To support the ...

Great AI doesn’t happen in isolation. These UX strategies — from confidence scores to graceful error recovery — turn users into active collaborators. The AI ...

The FDA recommends prioritizing overall survival as a primary endpoint in oncology trials, especially for diseases with short natural histories or existing OS-prolonging treatments. Trials should ...

The number of clinical trials conducted in China is rising dramatically. Historically, scientists have had concerns about the quality of research in China. Researchers within China have pushed to ...

Navigating the complexity of today’s drug development landscape grows more challenging every day with emerging and advanced biopharmaceuticals, vast amounts of data, new technologies, and evolving ...

Expanding clinical trial access locally reduces logistical and financial barriers, making participation feasible for underserved populations. Addressing myths about clinical trials helps patients ...

The Washington-based Providence health system has undertaken a rigorous research program, including randomized trials, to understand the impact of new technology deployments internally. Providence ...